| Line Item | 2026-04-03 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.42B | — | +6.8% |
| Cost of Revenue | $568.0M | — | +7.8% |
| Gross Profit | $854.0M | — | +6.1% |
| R&D Expense | $68.0M | — | +6.3% |
| SG&A Expense | $448.0M | — | +6.9% |
| Operating Income | $338.0M | — | +5.0% |
| Pre-tax Income | $321.0M | — | +11.1% |
| Income Tax | $67.0M | — | +4.7% |
| Net Income | $254.0M | — | +12.9% |
| EPS (Basic) | $1.03 | — | +13.2% |
| EPS (Diluted) | $1.02 | — | +13.3% |
| Line Item | 2026-04-03 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.43B | -29.5% | +15.5% |
| Accounts Receivable | $922.0M | +2.8% | +10.8% |
| Inventory | $332.0M | +8.1% | +7.1% |
| Current Assets | $2.94B | -14.2% | +15.1% |
| Total Assets | $7.65B | -0.5% | +15.2% |
| Current Liabilities | $1.98B |
| Line Item | 2026-04-03 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $182.0M | — | +15.9% |
| Capital Expenditures | $12.0M | — | -20.0% |
| Investing Cash Flow | -$439.0M | — | -3890.9% |
| Financing Cash Flow | -$332.0M | — | -1176.9% |
| Free Cash Flow | $170.0M | — | +19.7% |
| +69.6% |
| Long-term Debt | $2.66B | -0.4% | +1.2% |
| Stockholders' Equity | $3.00B | -3.2% | +30.5% |